MIRAPEXFor Patients and Caregivers

Doctors Talk about RLS

Type sizer AA

Watch leading physicians discuss the criteria for differential diagnosis of RLS, helping their patients describe the symptoms of RLS, and treatment with MIRAPEX.

The doctors who appear on this site have been compensated for their time by Boehringer Ingelheim Pharmaceuticals, Inc.

Having trouble seeing the image? Download ADOBE FLASH PLAYER by clicking here. Get ADOBE FLASH PLAYER

Email this page

Important Information about MIRAPEX: MIRAPEX is indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).

Patients have reported falling asleep without perceived warning signs during activities of daily living, including operation of a motor vehicle, which sometimes resulted in accidents. Hallucinations and postural (orthostatic) hypotension may occur. In clinical trials for RLS, the most commonly reported side effects of MIRAPEX that were more frequent than with placebo are nausea (16% vs. 5%), headache (16% vs. 15%), fatigue (9% vs. 7%) and somnolence (6% vs. 3%).

Patients and caregivers should be informed that impulse control disorders and compulsive behaviors have been reported in patients taking dopamine agonists, including MIRAPEX.

This information is intended for U.S. residents only. Products discussed herein may have different labeling in different countries.

Please see full Prescribing Information, including patient information.

If you can't afford your MIRAPEX, our patient assistance program may be able to help. Call 1-800-556-8317

If you can't afford your MIRAPEX, our patient assistance program may be able to help. Call 1-800-556-8317